Dr. Tse-Wen Chang, Chairman of T-E Meds and Dr. Hsing-Mao Chu, CEO of T-E Meds are honored speakers at the prestigious J.P. Morgan Healthcare Conference on February 21-22, 2024. Dr. Chang and Dr. Chu will share company updates, provide invaluable perspectives, and introduce revolutionary tech platforms and drug candidates.